human

Elon Musk’s Neuralink implants brain chip in first human

Elon Musk's Neuralink successfully implanted its brain chip in the first human patient, with promising neuron spike detection. The FDA approved the trial, aiming to assist patients with paralysis and neurological conditions. The company faced scrutiny over safety protocols and was fined for violating DOT rules. Neuralink's first product, Telepathy, is part of its PRIME Study for a wireless brain-computer interface.

Oxford starts human testing of Nipah virus vaccine

The University of Oxford has initiated human testing for an experimental vaccine against the Nipah virus, which has caused deadly outbreaks in Asia. The initial trial will assess safety and immune response and involves participants aged 18 to 55. The vaccine is based on the same technology used in AstraZeneca and Serum Institute of India's COVID-19 shots. The research is funded by the Coalition for Epidemic Preparedness Innovations. Further trials in Nipah-affected countries are anticipated.